Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer

doi:10.12998/wjcc.v10.i36.13304

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2115)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

101

WORD

HTML

975

Figures (1-2)

255

Tables (1-4)

175

Sum=1543

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

164

Download

408

Sum=572

Dec 26, 2022 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 26, 2022; 10(36): 13304-13312
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304

Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curve of Spondin-2 in the diagnosis of cervical cancer.

Citation: Zhang LL, Lin S, Zhang Y, Yao DM, Du X. Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer. World J Clin Cases 2022; 10(36): 13304-13312
URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13304.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13304